🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
People with asthma suffer from breathlessness because the small tubes (bron...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-07-20
Trial ID
NCT01400906
Treatments Being Tested
MKC-NI-002 is a Phase 1b, randomized, double-blind, placebo-controlled stud...
Status
Completed
Location
VALDI
Start Date
2025-12-22
Trial ID
NCT07344558
Treatments Being Tested
This is an initial proof of concept, phase to study to assess the safety an...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2005-03
Trial ID
NCT00150397
Treatments Being Tested
This study was designed to investigate the 1 year efficacy and safety of th...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-06
Trial ID
NCT00929110
Treatments Being Tested
Beta-endorphins, which are naturally occurring narcotic substances, have be...
Status
Completed
Location
Dartmouth-Hitchcock Medical Center
Start Date
2011-06
Trial ID
NCT01378520
Treatments Being Tested
The purpose of this study is to evaluate the safety and the efficacy of Gly...
Status
Completed
Location
Medicines Evaluation Unit
Start Date
2010-08
Trial ID
NCT01176903
Treatments Being Tested
GSK159802 is a potent, inhaled, long acting selective beta-2-receptor agoni...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-08-24
Trial ID
NCT00364273
Treatments Being Tested
To evaluate the efficacy and safety of TQC3721 inhalation powder in patient...
Status
Completed
Location
The Second Affiliated Hospital of Chongqing Medical University
Start Date
2025-12-22
Trial ID
NCT07252908
Treatments Being Tested
The purpose of this study is to demonstrate the pharmacodynamic bioequivale...
Status
Completed
Location
Combined Research Orlando
Start Date
2018-10-17
Trial ID
NCT03394989
This study is designed to provide data about the 24 hours FEV1 profile, saf...
Status
Completed
Location
Novartis Investigator Site
Start Date
2007-11
Trial ID
NCT00557440